Biomarker: I071-IgE Whole Body: Mosquito

Overview

This biomarker measures serum allergen-specific immunoglobulin E (IgE) antibodies that bind proteins in a mosquito whole-body extract. IgE contributes to immediate hypersensitivity reactions, although mosquito-bite reactions can also involve delayed cellular and other immune mechanisms. A detectable or elevated result indicates sensitization to the tested mosquito extract, but does not by itself establish clinically significant mosquito allergy or predict reaction severity. The test may support evaluation of recurrent, unusually large, or systemic reactions after mosquito exposure when interpreted with the clinical history and, when appropriate, skin testing.

Clinical Use Cases

Supporting evaluation of suspected IgE-mediated hypersensitivity to mosquito bites.
Investigating immediate wheal-and-flare reactions, marked local swelling, generalized urticaria, or rare systemic reactions after mosquito exposure.
Assessing sensitization when skin testing is unsuitable because of extensive skin disease, dermatographism, or inability to discontinue interfering medications.
Supporting clinical or epidemiologic research on mosquito allergen sensitization.
Comparing sensitization patterns in studies of mosquito species, extracts, or allergen components.

Specimen Types

Serum or plasma obtained from venous blood, depending on the assay.
Whole blood is collected initially, but testing is generally performed on the separated serum or plasma fraction.

Measurement Methods

Solid-phase allergen-specific IgE immunoassay.
Fluorescence enzyme immunoassay or other automated enzyme immunoassay platforms.
Enzyme-linked immunosorbent assay, primarily in research settings.
Radioallergosorbent testing, an older method that is now used infrequently.
Immunoblotting, mainly for research characterization of IgE-binding mosquito proteins.

Test Preparation and Influencing Factors

Fasting is generally not required for an allergen-specific IgE blood test.
Antihistamines usually do not interfere with serum-specific IgE measurement, unlike many skin tests. Medication changes should still be discussed with the ordering clinician.
A recent mosquito exposure or the interval since exposure may influence antibody concentrations. Studies have reported seasonal increases in mosquito antisaliva IgE after repeated exposure.
Results may vary according to mosquito species, geographic exposure, extract composition, and the amount of salivary allergen represented in the whole-body extract.
Whole-body extracts may contain relatively small amounts of clinically relevant salivary allergens and may include proteins that contribute to cross-reactive or clinically irrelevant binding.
Total IgE, atopic disease, age, sex, and other immune factors can affect interpretation of specific IgE concentrations.
A positive result indicates sensitization and must be interpreted with the exposure history and symptoms. It does not reliably determine the severity of a future reaction.
A negative result does not exclude mosquito-related disease when the extract does not adequately represent the relevant species or salivary allergen, or when the reaction is primarily delayed rather than IgE-mediated.